Semisynthesis Information & Semisynthesis Links at HealthHaven.com
advertise
add site
services
publishers
database
health videos
Bookmark and Share

search wiki for    ?
web dir firms image gallery news pdf wiki shop video 
about
toolbar
stats
live show
health store
more stuff
JOIN/LOGIN
Featured Results:
A GREEN LIGHT TO START PRODUCTION OF SEMISYNTHETIC PACLITAXEL
A GREEN LIGHT TO START PRODUCTION OF SEMISYNTHETIC PACLITAXEL
indena.com
 Leukemia patients were recommended daily dose of 5 mg/m2day of...
Leukemia patients were recommended daily dose of 5 mg/m2day of...
rockymountainbmt.com
 

"Semisynthesis" or partial chemical synthesis is a type of chemical synthesis that uses compounds isolated from natural sources (e.g. plant material or bacterial or cell cultures) as starting materials. These natural biomolecules are usually large and complex molecules. This is opposed to a total synthesis where large molecules are synthesized from a stepwise combination of small and cheap (petrochemical) building blocks.

Semisynthesis is usually used when the precursor molecule is too structurally complex, too costly or too inefficient to be produced by total synthesis. It is also possible that the semisynthetic derivative outperforms the original biomolecule itself with respect to potency, stability or safety.

Drugs derived from natural sources are usually produced by harvesting the natural source or through semisynthetic methods: one example is the semisynthesis of LSD from ergotamine, which is isolated from ergot fungus cultures. The commercial production of paclitaxel is also based on semisynthesis (see: paclitaxel total synthesis).

The antimalarial drug artemether (a component of Coartem) is a semisynthetic derived from naturally occurring artemisinin. The latter is unstable due to the presence of a lactone group and therefore this group is replaced by an acetal through organic reduction with potassium borohydride and methoxylation [1]:

Artemether semisynthesis from artemisinin

[edit] See also

[edit] References

  1. ^ An Improved Manufacturing Process for the Antimalaria Drug Coartem. Part IMatthias Boehm, Peter C. Fuenfschilling, Matthias Krieger, Ernst Kuesters, and Fritz Struber Org. Process Res. Dev.; 2007; 11(3) pp 336 - 340; (Article) doi:10.1021/op0602425



Product Results (view all...)

search wiki for    ?
web dir firms image gallery news pdf wiki shop video 



↑ top of page ↑about thumbshots